The market was valued at USD 181.5 million in 2024 and is anticipated to reach USD 348.13 million by 2035. This represents a steady expansion at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period from 2025 to 2035.
Global Medical Imaging Phantoms Market Size, Trend & Opportunity Analysis Report, by Application (Calibration & Quality Assurance, Diagnostic Imaging, Research & Development, Training & Education, Therapeutic Applications), Product (CT (Computed Tomography) Phantoms, MRI (Magnetic Resonance Imaging) Phantoms, Ultrasound Phantoms, X-ray Phantoms, Nuclear Medicine Phantoms, Others), End-use (Hospitals & Diagnostic Imaging Centersm, Medical Device Manufacturers, Others), and Forecast, 2025-2035
Report Code: LSMD510Author Name: Isha PaliwalPublication Date: October 2025Pages: 295
Available In:
Global Medical Imaging Phantoms Market Size, Opportunity Analysis and Forecast, 2025-2035
Publication Date: Oct 22, 2025Pages: 295
Medical Imaging Phantoms Market Definition and Introduction
The Global Medical Imaging Phantoms Market was valued at USD 192.57 Million in 2025 and is anticipated to reach USD 354.75 Million by 2035, expanding at a CAGR of 6.30% during the forecast period 2025-2035. Calibration at its best function of medical imaging phantoms. They hold a crucial place for clinicians and researchers, ensuring accurate imaging systems with less live testing. Like everything else in radiology, phantoms have emerged as the unsung heroes of medical imaging precision-with the advent of AI-assisted diagnostics, hybrid modalities, and value-driven imaging workflows. Severe pressure is being thrust upon healthcare systems globally to meet safety and quality standards while improving their sharper, reproducible diagnostic outputs. This scenario has further expedited the push for imaging phantoms across MRI, CT, PET, and ultrasound, hybrid modalities in the world as quality and standardisation assets.
Key Market Trends & Analysis
- Medical Imaging Phantoms Market size reached USD 192.57 Million in 2025, reflecting expanding demand for imaging validation.
- Market growth trends indicate a 6.30% CAGR during 2025-2035, supported by diagnostic imaging adoption and healthcare R&D investments.
- Medical Imaging Phantoms Market is projected to reach USD 354.75 Million by 2035, highlighting sustained industry expansion.
- Increasing diagnostic imaging adoption, ageing populations, chronic diseases, and precision medicine requirements are driving phantom demand globally.
- Calibration and quality assurance dominate market segmentation, driven by regulatory requirements for imaging accuracy, reproducibility, and patient safety.
- Diagnostic imaging applications are expanding as advanced modalities, including hybrid systems and photon-counting CT, require sophisticated validation tools.
- North America leads the Medical Imaging Phantoms Market, supported by advanced healthcare infrastructure, regulatory compliance, and extensive imaging technology adoption.
- The U.S. remains the leading country, supported by imaging innovation, FDA-aligned R&D pipelines, and increasing AI diagnostic adoption.
- Asia-Pacific represents the fastest-growing regional market, driven by healthcare investment, improved imaging infrastructure, and domestic phantom manufacturing capabilities.
- In March 2025, Modus Medical Devices announced research investment targeting new phantom models for photon-counting CT systems and advanced imaging validation.
Medical Imaging Phantoms Market Size and Growth Projection:
- Market Size in 2025: USD 192.57 Million
- Market Size by 2035: USD 354.75 Million
- CAGR: 6.30% from 2025 to 2035
- Base Year: 2025
- Forecast Period: 2026–2035
- Historical Data: 2022–2024
Quality frontiers, the importance of phantoms now extends into innovation. Medical research infrastructures and device manufacturers make extensive use of phantoms in not only validating new operating protocols of imaging but also assessing reconstruction algorithms powered by artificial intelligence and creating technologies being developed, like photon-counting CT or advanced molecular imaging. As healthcare progresses in shifting towards more personal diagnostics, phantoms evolve and develop into sophisticated surrogates that accurately replicate human tissue heterogeneity for high-fidelity simulations of real-world imaging scenarios.
Increasing demand for non-invasive procedures coupled with an increase in R&D investments, the manufacturers of these devices have been compelled to develop high-efficiency phantoms capable of replicating complex anatomical structures while including traceable calibration features. The new era of precision in healthcare currently drives a very energetic wave of innovation and competition, as companies strive to integrate ingenuity with regulatory compliance as they prepare for the next generation of imaging-validation tools.
Recent Developments in the Medical Imaging Phantoms Industry
- In January 2024, Kyoto Kagaku introduced the next generation of multi-modality phantoms that reproduce ultra-realistic tissue properties for CT, MRI, and ultrasound. This innovation allows radiology trainees and clinical researchers to develop skills and standardise diagnostic practices.
- In July 2024, CIRS Inc. (a Sun Nuclear Company) released AI-ready phantom solutions tailored for validating deep learning models in diagnostic imaging. These phantoms provide traceable references for algorithm benchmarking, ensuring robustness and reliability in machine learning applications.
- In April 2023, PTW Freiburg GmbH presented a next-generation dosimetry phantom designed for combined radiotherapy-imaging applications. This development considers the growing need for hybrid treatment workflows and allows for the precise monitoring of doses supported by real-time imaging.
- In February 2024, Biodex Medical Systems Inc. (a Mirion Technologies company) partnered with leading distributors in Europe to strengthen the availability of its ultrasound and nuclear medicine phantoms, responding to increasing regional demand for quality assurance solutions.
- In March 2025, Modus Medical Devices Inc. announced a focused research investment to develop new phantom models for photon-counting CT systems, set to revolutionise diagnostic imaging resolution and clinical efficiency.
Medical Imaging Phantoms Market Dynamics: Drivers, Restraints, Opportunities, Challenges and Trends
Rising Diagnostic Imaging Adoption Accelerates Medical Imaging Phantom Market Growth Across Healthcare Settings.
Demand for diagnostic imaging is increasing, substantially because of an ageing population and chronic diseases, resulting in a rapidly rising reliance on precision-based medicine. Imaging phantoms are an integral part of calibration and validation in hospitals or diagnostic centres to allow adherence to very refined standards of image quality and safety of patients with all kinds of modality integration.
Regulatory Compliance Accelerates Medical Imaging Phantom Innovation Through Advanced Design and Quality Assurance Systems.
Phantom use has become an inevitable part of today for routine system validation and clinical trial imaging with stringent compliance from the FDA, EMA, and ISO. Manufacturers invest in the most modern materials that replicate those of real tissue densities and incorporate even traceable calibration markers. It clearly shows that the industry now strives for a highly specialised, regulatory-compliant design in phantoms that are accurate as well as durable.
Rising R&D Investments Accelerate Medical Imaging Phantom Innovation Across AI, CT, and Molecular Imaging Technologies.
In the last few decades, research organisations, as well as manufacturers of imaging equipment, have been spending most of their research resources on phantoms, because new technologies-development-from artificial intelligence image analysis, particle-counting CTs, to molecular imaging-need phantoms that can reproduce human tissue complexities in considerable fidelity. Today's status of phantoms as a really enabling factor of imaging innovation is recognised.
High Costs and Limited Local Manufacturing Restrain Medical Imaging Phantom Adoption Across Emerging Markets.
While the advanced phantoms are being adopted by developed markets, it does not include their high price and limited local manufacturing capabilities, thus restricting their usage in price-sensitive regions. Barriers to importation-which are aggravated by supply chain constraints-pose some of the major problems to the smaller diagnostic centres in Asia, Africa, and Latin America.
Hybrid and Personalized Imaging Create New Growth Opportunities for Advanced Medical Imaging Phantom Applications.
The future of next-generation phantoms is being created in this fertile ground since radiology, nuclear medicine, and AI are converging. In this case, the hybrid imaging phantoms for validating protocols across modalities or those involving patient-specific anatomical models for personalised treatment planning promise to provide tremendous opportunities for transformative growth.
Where Are the Biggest Opportunities in the Medical Imaging Phantoms Market?
- AI-Driven Imaging Validation - Development of AI-ready phantoms accelerates algorithm benchmarking for diagnostic accuracy.
- Photon-Counting CT Phantoms - Emerging demand for validation models tailored to ultra-high-resolution CT technology.
- Hybrid Therapy Support - Phantom designs for combined radiotherapy-imaging workflows enable cross-disciplinary treatment precision.
- 3D Printed Custom Phantoms - Personalised phantom manufacturing delivers anatomically accurate models for clinical trial support.
- Eco-Friendly Phantom Materials - Use of sustainable, biocompatible materials reduces environmental and manufacturing footprint.
- Emerging Market Expansion - Growing healthcare investment in Asia-Pacific and Latin America drives phantom adoption.
- Academic-Industry Partnerships - Collaborations between universities and manufacturers accelerate innovation in phantom development.
- Training and Education Surge - Phantoms are increasingly utilised for skill development and radiology workforce training.
- Regulatory Compliance Growth - Heightened global imaging standards reinforce phantom integration into QA protocols.
- R&D Commercialisation Pathways - Translating phantom-based prototypes into scalable imaging solutions opens new revenue streams.
Medical Imaging Phantoms Market Segmentation Analysis
Report Attributes | Details |
Market Size in 2025 | USD 192.57 Million |
Market Size by 2035 | USD 354.75 Million |
CAGR (2026-2035) | 6.30% |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Historical Data | 2022-2024 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, Analysis, Forecast Outlook |
Key Segments | By Application: Calibration & Quality Assurance, Diagnostic Imaging, Research & Development, Training & Education, Therapeutic Applications By Product: CT (Computed Tomography) Phantoms, MRI (Magnetic Resonance Imaging) Phantoms, Ultrasound Phantoms, X-ray Phantoms, Nuclear Medicine Phantoms, Others By End-use: Hospitals & Diagnostic Imaging Centersm, Medical Device Manufacturers, Others |
Regional Analysis/Coverage | North America (U.S, Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, rest of Asia Pacific), LAMEA (Latin America, Middle East, and Africa) |
Company Profiles | Kyoto Kagaku Co., Ltd., CIRS Inc. (a Sun Nuclear Company), PTW Freiburg GmbH, Biodex Medical Systems Inc. (Mirion Technologies), Gammex Inc., Modus Medical Devices Inc., PhantomX, Leeds Test Objects Ltd., True Phantom Solutions Inc., and RTI Group |
Medical Imaging Phantoms Market: Dominating Segments
Calibration and Quality Assurance Lead Medical Imaging Phantom Demand Through Accuracy, Reproducibility, and Regulatory Compliance.
Calibration and quality assurance are the primary users of phantoms, as regulatory requirements demand that systems are validated regularly around the world to guarantee image accuracy and patient safety. Phantoms for calibration made for CT, MRI, ultrasound, and PET/CT systems ensure reproducibility of performance in diagnostic environments. These phantoms are being used at hospitals and in diagnostic centres to meet the global regulatory requirements, especially together with the increasing sophistication and integration of the imaging techniques.
Diagnostic Imaging Growth Accelerates Medical Imaging Phantom Demand Through Advanced Modalities and Protocol Standardization.
Diagnostic imaging has grown to an unimaginable extent under the pressure of an ageing demographic and the rise of chronic diseases. Phantoms in this area allow radiologists to standardise imaging protocols, train workforce personnel, and start validating new imaging algorithms. Hybrid systems such as PET/MRI and photon-counting CT are growing the scope of phantoms even further, since these new modalities require more elaborate tools for validation.
R&D Applications Accelerate Medical Imaging Phantom Market Growth Through AI, Hardware Innovation, and Clinical Trial Standardization.
Phantoms are gaining valuable traction in the R&D environment towards the advancement of new imaging hardware, reconstruction algorithms, and standardisation of clinical trials. From AI-based diagnostic models to next-generation imaging modalities, phantoms provide the reproducible testing conditions that are so vital in clinching the transfer of theoretical research into clinical applications. The use of phantoms in academic-industrial partnerships is also on the rise, with universities and manufacturers collaborating to develop customised phantoms that imitate patient-specific anatomical structures.
Regional Insights in the Medical Imaging Phantoms Market
North America Leads the Medical Imaging Phantom Market Through Advanced Healthcare Infrastructure and Regulatory Compliance.
North America is the foremost region in the medical imaging phantoms market as it boasts of strong healthcare systems, the most extensive adoption of imaging techniques, and a demanding regulatory environment. Particularly, the U.S., where it is a major hub for innovation in imaging, supported by wide-ranging research and development pipelines lined up with FDA regulations, allows phantoms to be part of the system validation. Increased demand for AI-based diagnostic solutions has put more weight on phantoms to maintain confidence and reproducibility.
Europe Advances Medical Imaging Phantom Innovation Through Strict Regulations, Sustainable Materials, and Multimodality Designs.
Europe is, therefore, the first user of phantoms, all due to its strict regulation in this respect, and coupled with the EU's effort to direct harmonised health care standards across the continent. Germany, the UK, and France are active participants, with rising investments in green materials and multi-modality designs for phantoms. Much collaboration between university and industry players is taking place to scale up the increasing demand for hybrid imaging and AI validation, both in clinical and research settings.
Asia-Pacific Leads Medical Imaging Phantom Growth Through Healthcare Investment, Imaging Infrastructure, and Local Manufacturing.
Asia-Pacific emerges as the fast-growing regional market due to increased investment in healthcare, improved imaging infrastructure, and the establishment of domestic phantom manufacturing capabilities. China, India, and South Korea are adopting such governments' encouragement policies on training and innovation regarding diagnostic imaging. High patient numbers and continuing research activity will provide a more balanced future for clinical and educational applications of phantoms.
LAMEA Medical Imaging Phantom Adoption Grows Through Healthcare Modernization, Diagnostic Infrastructure, and Regional Training Programs.
The three regions of Latin America, the Middle East, and Africa are now incrementally adopting medical imaging phantoms due to healthcare modernisation efforts and increased investments in diagnostic infrastructure. Lack of cost-effective equipment was a barrier to use in some areas, but other initiatives to advance radiology training and regulatory alignment foster increased phantom use. Global partnerships further help close accessibility and innovation gaps.
How Can Stakeholders Benefit from the Medical Imaging Phantoms Market Report?
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.
Frequently Asked Questions
The Calibration and Quality Assurance (QA) segment is the dominant application. This leadership is driven by stringent global regulatory requirements (such as FDA, EMA, and ISO) that mandate regular system validation to ensure image accuracy, reproducibility, and patient safety across various modalities like CT, MRI, and ultrasound.
AI is a major catalyst for innovation, leading to the development of "AI-ready" phantoms. These specialized tools, such as those released by CIRS Inc. in 2024, provide traceable references for benchmarking deep learning models and validating reconstruction algorithms, ensuring the robustness of machine learning applications in diagnostics.
Key drivers include the rising global demand for diagnostic imaging due to aging populations and chronic diseases, the shift toward precision-based medicine, the emergence of hybrid imaging modalities (like PET/MRI), and the increasing need for high-fidelity surrogates to test next-generation technologies like photon-counting CT.
North America currently leads the market due to its advanced healthcare infrastructure and strict regulatory environment. However, the Asia-Pacific region is the fastest-growing market, fueled by increased healthcare investments, expanding imaging capacity, and the development of domestic manufacturing capabilities in countries like China and India.
The primary obstacles include the high cost of advanced phantoms and limited local manufacturing in price-sensitive regions. Additionally, material limitations in replicating complex human tissue heterogeneity and supply chain constraints in LAMEA (Latin America, Middle East, and Africa) pose challenges for smaller diagnostic centers.
Phantoms are considered essential enabling factors for photon-counting CT. Manufacturers like Modus Medical Devices Inc. are investing in new phantom models specifically designed to validate the ultra-high-resolution and clinical efficiency of these systems, which are set to revolutionize diagnostic imaging.
3D printing offers an attractive opportunity for the production of personalized, custom phantoms. This technology allows for the manufacturing of anatomically accurate models that mimic patient-specific structures, which is particularly valuable for clinical trial support and personalized treatment planning.
In early 2024, Kyoto Kagaku introduced next-generation multi-modality phantoms with ultra-realistic tissue properties. Additionally, PTW Freiburg GmbH launched a dosimetry phantom in 2023 specifically designed for hybrid radiotherapy-imaging workflows to monitor real-time radiation doses.
The market features several prominent players, including Kyoto Kagaku Co., Ltd., CIRS Inc. (Sun Nuclear), PTW Freiburg GmbH, Biodex Medical Systems Inc. (Mirion Technologies), Gammex Inc., Modus Medical Devices Inc., and the RTI Group. These companies are increasingly focused on academic-industry partnerships to accelerate R&D.
